BJDX - Company ID 0001704287
The table below shows Bluejay Diagnostics, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$1.59M | -$1.18M | -$2.30M | -$2.93M | -$1.88M | -$372.62K |
| Capital expenditure | $18.99K | - | $35.43K | $340.67K | $46.35K | - |
| Investing cash flow | -$15.31K | - | -$35.43K | -$340.67K | -$46.35K | - |
| Dividends paid | - | - | - |
Bluejay Diagnostics, Inc. reported operating cash flow of -$6.05M for fiscal year 2025. That is up 22.6% from -$7.82M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$508.71K (FY 2020) to -$6.05M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | $57.60K | - | - |
| Financing cash flow | $124.10K | -$985.00 | $2.79M | -$58.80K | - | -$290.75K |